Baxter International Inc., of Deerfield, Ill., filed a complaint with the U.S. International Trade Commission alleging that Novo Nordisk A/S, of Bagsvaerd, Denmark, violated the Tariff Act in importing certain recombinant Factor VIII products into the U.S.